Novavax is trading at $10.21, up 5.27%, alongside strength across biotech.
- XBI was up 2.13% during the regular session, while broader markets were also sharply higher, supporting a risk-on backdrop.
- No fresh company-specific announcement explaining the intraday move surfaced in the search. Investors are looking ahead to Novavax’s scheduled third-quarter results on November 5; the report is context, not a confirmed cause.